Table 3.

Characteristics and outcomes of received cases

Case	Case demographics	Valvular disease	Prior ADR to BPG	Type of BPG administered	Time to adverse event	Brighton criteria	Outcome
1	Female, 12, Timor Leste	Yes	No*	Powdered	Immediate	Level 2	Death
2	Female, 12, India	Yes	No	Powdered	Immediate	Uncertain†	Death
3	Male, 13, Egypt	Yes	Yes	Powdered	Immediate	Did not meet criteria	Full recovery
4	Female, 15, Uganda	Yes	No	Powdered	Immediate	Did not meet criteria	Death
5	Female, 16, Nepal	Yes	No	Powdered	<1 hour	Level 1	Death
6	Male, 17, Uganda	Yes	No	Powdered	Immediate	Uncertain†	Death
7	Female, 19, Nepal	Yes	No	Powdered	<1 hour	Level 2	Full Recovery
8	Female, 24, Nepal	Yes	No	Powdered	<1 hour	Level 1	Death
9	Male, 32, Uganda	Yes	No	Powdered	Immediate	Uncertain†	Death
10	Male, 35, Nepal	Yes	No	Powdered	<1 hour	Level 1	Death

*First dose of BPG.

†Unable to assess due to missing data.

ADR, adverse drug reaction; BPG, benzathine penicillin G.